The iFuse is a minimally invasive surgical system including titanium implants. The implants are coated with a porous plasma spray to regulate and decrease implant motion.
The system is indicated for use by the FDA for fracture fixation of large bones and large bone fractures of the pelvis.
Read the Science 2.0 report about iFuse.
Read other coverage on SI-BONE:
– SI-BONE Closes $11M Financing for Commercial and Clinical Expansion
– SI-BONE Begins Post-Market Clinical Experience of iFuse Implant Device
– SI-BONE Launches iFuse Implant System in Europe
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
